Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

Clinical Applications of Epidermal Stem Cells

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Nodular Secondary Syphilis: Systematic Review of an Underrecognized Clinical Phenotype.

International journal of dermatology·2026

Same author

Nodular secondary syphilis in a patient who was immunocompetent: a sporotrichoid masquerader with synchronous primary lesion.

Skin health and disease·2026

Same author

Type C Lymphomatoid Papulosis Following Immune Checkpoint Inhibition in a Melanoma Patient: A Reactive Mimicker of Cutaneous CD30<sup>+</sup> Lymphoma.

Dermatology practical & conceptual·2026

Same author

Clinicopathologic Features and Treatment Outcomes of Squamoid Eccrine Ductal Carcinoma: A Comprehensive Retrospective Series.

The American Journal of dermatopathology·2026

Same author

Investigating the analytical robustness of the social and behavioural sciences.

Nature·2026

Same author

PRAME Expression in Melanoacanthomas: Expanding the Spectrum of Positive Melanocytes in Sun-Exposed Skin.

Dermatopathology (Basel, Switzerland)·2026

Search research articles

Related Experiment Video

Updated: Dec 23, 2025

Murine Model of Epicutaneously-Induced Immunomodulation

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

Small-molecule-based immunotherapy for immunologically mediated skin conditions.

Alvise Sernicola¹, Irene Russo¹, Mauro Alaibac¹

¹Unit of Dermatology, University of Padua, Via Gallucci 4, 35128 Padova, Italy.

|April 21, 2020

Summary

Small-molecule inhibitors offer a promising new approach for treating skin immune disorders by targeting inflammation pathways. These agents are easily administered and have a favorable safety profile, improving therapeutic outcomes.

Keywords:

apremilast atopic dermatitis cutaneous immune disorders psoriasis receptor-associated kinases small molecules

More Related Videos

Development of an Economical DNA Delivery System by "Acufection" and its Application to Skin Research

Development of an Economical DNA Delivery System by "Acufection" and its Application to Skin Research

Published on: April 19, 2017

Intralymphatic Immunotherapy and Vaccination in Mice

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Related Experiment Videos

Last Updated: Dec 23, 2025

Murine Model of Epicutaneously-Induced Immunomodulation

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

Development of an Economical DNA Delivery System by "Acufection" and its Application to Skin Research

Development of an Economical DNA Delivery System by "Acufection" and its Application to Skin Research

Published on: April 19, 2017

Intralymphatic Immunotherapy and Vaccination in Mice

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Area of Science:

Immunodermatology
Pharmacology
Molecular Biology

Background:

Advances in understanding skin immune disorders have driven pharmaceutical innovation.
Small-molecule inhibitors represent a new class of drugs for managing inflammatory skin conditions.

Purpose of the Study:

To review emerging small-molecule inhibitors for cutaneous immune disorders.
To highlight agents targeting key inflammatory pathways.

Main Methods:

Literature review of small-molecule inhibitors in development.
Focus on inhibitors targeting receptor-associated kinases, second messengers, and transcription factors.

Main Results:

Small molecules modulate intracellular targets in proinflammatory pathways.
These agents demonstrate potential for improved efficacy and safety.

Conclusions:

Small-molecule inhibitors are a promising therapeutic strategy for various skin immune conditions.
Their favorable pharmacokinetic and safety profiles enhance treatment potential.